Status
Conditions
Treatments
About
Laparoscopic cholecystectomy is a common keyhole surgery to remove the gallbladder. Although the cuts are small, patients can still have significant pain and nausea after the operation, which may delay recovery and discharge. To improve comfort, doctors often use ultrasound-guided abdominal nerve blocks as part of multimodal pain management.
In this single-center, randomized controlled trial, adult patients scheduled for elective laparoscopic cholecystectomy will receive standard general anesthesia and be randomly assigned to one of two routinely used block techniques at the end of surgery: (1) a 4-point transversus abdominis plane (TAP) block, or (2) a combined bilateral rectus sheath block plus oblique subcostal TAP block. Both techniques are performed under ultrasound guidance while the patient is still asleep.
The main aim of the study is to compare the quality of recovery on the first day after surgery between the two groups, using a short questionnaire (QoR-15). Secondary aims are to compare pain scores, the need for additional pain medicine, and the frequency of postoperative nausea and vomiting between the groups during the first 24 hours. All other aspects of anesthesia and surgical care will follow standard hospital practice. Participation is not expected to add significant risk beyond that of routine anesthesia and surgery, as both block techniques are already commonly used in clinical practice.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Adults aged 18-65 years
ASA physical status I-II
Scheduled for elective laparoscopic cholecystectomy
Ability to understand the study and provide written informed consent
Exclusion criteria
Allergy or hypersensitivity to local anesthetics or study medications
Coagulopathy, anticoagulant therapy, or local infection at block site
Severe pulmonary disease (severe COPD, uncontrolled asthma, respiratory failure)
NYHA class III-IV heart failure
History of thoracic or abdominal surgery affecting block area
Chronic pain syndrome or regular opioid/analgesic use
Morbid obesity (BMI > 35 kg/m²)
Pregnancy or breastfeeding
Cognitive impairment preventing cooperation
Conversion to open cholecystectomy
-
Primary purpose
Allocation
Interventional model
Masking
76 participants in 2 patient groups
Loading...
Central trial contact
Esma karaarslan, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal